Insulet Corp. PODD recently announced positive results from its Omnipod 5 Automated Insulin Delivery System (Omnipod 5) type ...

Insulet (NASDAQ:PODD) announced Friday that its tubeless insulin delivery system, Omnipod 5, performed better than conventional insulin pumps in a clinical trial for patients with type 1 diabetes.

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

The Omnipod system is relatively expensive. We found that a 5-pack of Omnipods (each lasting 72 hours) costs between $250 and $400. That is 15 days worth of treatment, so you would need two refills or ...

Omnipod 5, a New Focus: Insulet’s game-changing Omnipod 5 stands out as the only FDA-cleared, fully disposable pod-based AID system. The product attributes, such as on-body wearable, simplicity ...

Learn about the latest research in smart insulin. Know how these advancements are transforming diabetes management and ...

OKLAHOMA CITY — Medicaid recipients in Oklahoma who have diabetes may benefit from a proposed change in the way the state covers costs of automated insulin management systems. On Monday ...

SG Americas Securities LLC decreased its holdings in shares of Insulet Co. (NASDAQ:PODD – Free Report) by 70.4% in the 3rd ...

It specializes in diabetes supplies, including the OmniPod System, as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps ...

Explosive mech action your bag? It's time to prepare for a new era of mechanised warfare with MechWarrior 5 on Game Pass, ...